INVESTOR NEWS
Investor News
Corporate News
2026
- Sep 8, 2026innoscripta expands business in established Austrian market – order backlog exceeds EUR 1 million
- Aug 25, 2026innoscripta SE: Successful First Half of 2026
- Aug 12, 2026innoscripta SE: Successful US Market Entry – Clusterix Addresses New IRS Documentation Requirements under Form 6765
- Jul 29, 2026innoscripta SE Launches Expansion into the United Kingdom
- Jul 8, 2026innoscripta SE Accelerates Regional Expansion with New Hamburg Office
- Jun 23, 2026innoscripta SE wins first customers in France and accelerates international expansion
- May 26, 2026innoscripta SE: Strong first quarter
- May 6, 2026innoscripta Wins Global Logistics Player as New Client
- Apr 22, 2026innoscripta SE: Annual General Meeting approves dividend of EUR 4.00 per share and confirms Supervisory Board with strong capital markets expertise
- Apr 15, 2026innoscripta drives expansion in Europe: Market entry in France completed
- Mar 19, 2026innoscripta SE Expands into the Rhine-Main Growth Region and Strengthens Its Positioning as a Leading R&D Platform Provider with a New Office in Frankfurt
- Mar 4, 2026innoscripta SE leads listed German companies in the Financial Times/Statista ranking
- Jan 27, 2026innoscripta SE publishes Preliminary Annual Results for 2025
2025
- Nov 3, 2025innoscripta reports successful third quarter of 2025
- Oct 29, 2025innoscripta SE announces publication of Q3 figures for 2025
- Aug 21, 2025innoscripta reports successful first half of 2025
- Aug 6, 2025innoscripta SE announces publication of half-year figures for 2025
- Jun 17, 2025innoscripta SE: Founders Plan Selective Share Purchases to Support Share Price
- Jun 10, 2025innoscripta SE: Cabinet draft provides for 20% flat-rate surcharge and increased funding cap for R&D tax incentive starting in 2026
- May 15, 2025innoscripta SE announces price range and offer structure for planned IPO
- May 6, 2025innoscripta AG plans Initial Public Offering in the second quarter of 2025
Ready to explore investment opportunities?
ir@innoscripta.com
+49 (0)89 255 553 509
Max Hunger
Head of Investor Relations
